Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.

David J. Kaczorowski, Melanie J. Scott, John P. Pibris, Amin Afrazi, Atsunori Nakao, Rebecca D. Edmonds, Sodam Kim, Joon H. Kwak, Yujian Liu, Jie Fan, Timothy R. Billiar

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Complement factor B plays a critical role in ischemic tissue injury and autoimmunity. Factor B is dynamically synthesized and released by cells outside of the liver, but the molecules that trigger local factor B synthesis and release during endogenous tissue injury have not been identified. We determined that factor B is upregulated early after cold ischemia-reperfusion in mice, using a heterotopic heart transplant model. These data suggested upregulation of factor B by damage-associated molecular patterns (DAMPs), but multiple common DAMPs did not induce factor B in RAW264.7 mouse macrophages. However, exogenous DNA induced factor B mRNA and protein expression in RAW cells in vitro, as well as in peritoneal and alveolar macrophages in vivo. To determine the cellular mechanisms involved in DNA-induced factor B upregulation we then investigated the role of multiple known DNA receptors or binding partners. We stimulated peritoneal macrophages from wild-type (WT), toll-like receptor 9 (TLR9)-deficient, receptor for advanced glycation end products (RAGE)-/- and myeloid differentiation factor 88 (MyD88)-/- mice, or mouse macrophages deficient in high-mobility group box proteins (HMGBs), DNA-dependent activator of interferon-regulatory factors (DAI) or absent in melanoma 2 (AIM2), with DNA in the presence or absence of lipofection reagent. Reverse transcription-polymerase chain reaction, Western blotting and immunocytochemical analysis were employed for analysis. Synthesis of factor B was independent of TLR9, RAGE, DAI and AIM2, but was dependent on HMGBs, MyD88, p38 and NF-κB. Our data therefore show that mammalian DNA is an endogenous molecule that stimulates factor B synthesis and release from macrophages via HMGBs, MyD88, p38 and NF-κB signaling. This activation of the immune system likely contributes to damage following sterile injury such as hemorrhagic shock and ischemia-reperfusion.

Original languageEnglish
Pages (from-to)851-860
Number of pages10
JournalMolecular Medicine
Volume18
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Complement Factor B
DNA
HMGB Proteins
Myeloid Differentiation Factor 88
Interferon Regulatory Factors
Toll-Like Receptor 9
Macrophages
Peritoneal Macrophages
Reperfusion
Melanoma
Wounds and Injuries
Up-Regulation
Cold Ischemia
Hemorrhagic Shock
Alveolar Macrophages
Autoimmunity
Reverse Transcription
Immune System
Ischemia
Western Blotting

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kaczorowski, D. J., Scott, M. J., Pibris, J. P., Afrazi, A., Nakao, A., Edmonds, R. D., ... Billiar, T. R. (2012). Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. Molecular Medicine, 18, 851-860.

Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. / Kaczorowski, David J.; Scott, Melanie J.; Pibris, John P.; Afrazi, Amin; Nakao, Atsunori; Edmonds, Rebecca D.; Kim, Sodam; Kwak, Joon H.; Liu, Yujian; Fan, Jie; Billiar, Timothy R.

In: Molecular Medicine, Vol. 18, 2012, p. 851-860.

Research output: Contribution to journalArticle

Kaczorowski, DJ, Scott, MJ, Pibris, JP, Afrazi, A, Nakao, A, Edmonds, RD, Kim, S, Kwak, JH, Liu, Y, Fan, J & Billiar, TR 2012, 'Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.', Molecular Medicine, vol. 18, pp. 851-860.
Kaczorowski, David J. ; Scott, Melanie J. ; Pibris, John P. ; Afrazi, Amin ; Nakao, Atsunori ; Edmonds, Rebecca D. ; Kim, Sodam ; Kwak, Joon H. ; Liu, Yujian ; Fan, Jie ; Billiar, Timothy R. / Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B. In: Molecular Medicine. 2012 ; Vol. 18. pp. 851-860.
@article{04497877f470476892ba1ac7bec0e76b,
title = "Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.",
abstract = "Complement factor B plays a critical role in ischemic tissue injury and autoimmunity. Factor B is dynamically synthesized and released by cells outside of the liver, but the molecules that trigger local factor B synthesis and release during endogenous tissue injury have not been identified. We determined that factor B is upregulated early after cold ischemia-reperfusion in mice, using a heterotopic heart transplant model. These data suggested upregulation of factor B by damage-associated molecular patterns (DAMPs), but multiple common DAMPs did not induce factor B in RAW264.7 mouse macrophages. However, exogenous DNA induced factor B mRNA and protein expression in RAW cells in vitro, as well as in peritoneal and alveolar macrophages in vivo. To determine the cellular mechanisms involved in DNA-induced factor B upregulation we then investigated the role of multiple known DNA receptors or binding partners. We stimulated peritoneal macrophages from wild-type (WT), toll-like receptor 9 (TLR9)-deficient, receptor for advanced glycation end products (RAGE)-/- and myeloid differentiation factor 88 (MyD88)-/- mice, or mouse macrophages deficient in high-mobility group box proteins (HMGBs), DNA-dependent activator of interferon-regulatory factors (DAI) or absent in melanoma 2 (AIM2), with DNA in the presence or absence of lipofection reagent. Reverse transcription-polymerase chain reaction, Western blotting and immunocytochemical analysis were employed for analysis. Synthesis of factor B was independent of TLR9, RAGE, DAI and AIM2, but was dependent on HMGBs, MyD88, p38 and NF-κB. Our data therefore show that mammalian DNA is an endogenous molecule that stimulates factor B synthesis and release from macrophages via HMGBs, MyD88, p38 and NF-κB signaling. This activation of the immune system likely contributes to damage following sterile injury such as hemorrhagic shock and ischemia-reperfusion.",
author = "Kaczorowski, {David J.} and Scott, {Melanie J.} and Pibris, {John P.} and Amin Afrazi and Atsunori Nakao and Edmonds, {Rebecca D.} and Sodam Kim and Kwak, {Joon H.} and Yujian Liu and Jie Fan and Billiar, {Timothy R.}",
year = "2012",
language = "English",
volume = "18",
pages = "851--860",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",

}

TY - JOUR

T1 - Mammalian DNA is an endogenous danger signal that stimulates local synthesis and release of complement factor B.

AU - Kaczorowski, David J.

AU - Scott, Melanie J.

AU - Pibris, John P.

AU - Afrazi, Amin

AU - Nakao, Atsunori

AU - Edmonds, Rebecca D.

AU - Kim, Sodam

AU - Kwak, Joon H.

AU - Liu, Yujian

AU - Fan, Jie

AU - Billiar, Timothy R.

PY - 2012

Y1 - 2012

N2 - Complement factor B plays a critical role in ischemic tissue injury and autoimmunity. Factor B is dynamically synthesized and released by cells outside of the liver, but the molecules that trigger local factor B synthesis and release during endogenous tissue injury have not been identified. We determined that factor B is upregulated early after cold ischemia-reperfusion in mice, using a heterotopic heart transplant model. These data suggested upregulation of factor B by damage-associated molecular patterns (DAMPs), but multiple common DAMPs did not induce factor B in RAW264.7 mouse macrophages. However, exogenous DNA induced factor B mRNA and protein expression in RAW cells in vitro, as well as in peritoneal and alveolar macrophages in vivo. To determine the cellular mechanisms involved in DNA-induced factor B upregulation we then investigated the role of multiple known DNA receptors or binding partners. We stimulated peritoneal macrophages from wild-type (WT), toll-like receptor 9 (TLR9)-deficient, receptor for advanced glycation end products (RAGE)-/- and myeloid differentiation factor 88 (MyD88)-/- mice, or mouse macrophages deficient in high-mobility group box proteins (HMGBs), DNA-dependent activator of interferon-regulatory factors (DAI) or absent in melanoma 2 (AIM2), with DNA in the presence or absence of lipofection reagent. Reverse transcription-polymerase chain reaction, Western blotting and immunocytochemical analysis were employed for analysis. Synthesis of factor B was independent of TLR9, RAGE, DAI and AIM2, but was dependent on HMGBs, MyD88, p38 and NF-κB. Our data therefore show that mammalian DNA is an endogenous molecule that stimulates factor B synthesis and release from macrophages via HMGBs, MyD88, p38 and NF-κB signaling. This activation of the immune system likely contributes to damage following sterile injury such as hemorrhagic shock and ischemia-reperfusion.

AB - Complement factor B plays a critical role in ischemic tissue injury and autoimmunity. Factor B is dynamically synthesized and released by cells outside of the liver, but the molecules that trigger local factor B synthesis and release during endogenous tissue injury have not been identified. We determined that factor B is upregulated early after cold ischemia-reperfusion in mice, using a heterotopic heart transplant model. These data suggested upregulation of factor B by damage-associated molecular patterns (DAMPs), but multiple common DAMPs did not induce factor B in RAW264.7 mouse macrophages. However, exogenous DNA induced factor B mRNA and protein expression in RAW cells in vitro, as well as in peritoneal and alveolar macrophages in vivo. To determine the cellular mechanisms involved in DNA-induced factor B upregulation we then investigated the role of multiple known DNA receptors or binding partners. We stimulated peritoneal macrophages from wild-type (WT), toll-like receptor 9 (TLR9)-deficient, receptor for advanced glycation end products (RAGE)-/- and myeloid differentiation factor 88 (MyD88)-/- mice, or mouse macrophages deficient in high-mobility group box proteins (HMGBs), DNA-dependent activator of interferon-regulatory factors (DAI) or absent in melanoma 2 (AIM2), with DNA in the presence or absence of lipofection reagent. Reverse transcription-polymerase chain reaction, Western blotting and immunocytochemical analysis were employed for analysis. Synthesis of factor B was independent of TLR9, RAGE, DAI and AIM2, but was dependent on HMGBs, MyD88, p38 and NF-κB. Our data therefore show that mammalian DNA is an endogenous molecule that stimulates factor B synthesis and release from macrophages via HMGBs, MyD88, p38 and NF-κB signaling. This activation of the immune system likely contributes to damage following sterile injury such as hemorrhagic shock and ischemia-reperfusion.

UR - http://www.scopus.com/inward/record.url?scp=84876405811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876405811&partnerID=8YFLogxK

M3 - Article

C2 - 22526919

AN - SCOPUS:84876405811

VL - 18

SP - 851

EP - 860

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

ER -